Serina Therapeutics(SER)
$1.20-0.15 (-11.11%)
SER
Serina Therapeutics financials statements
$1.20
At close:-0.15 (-11.11%)
Want to see SER full AI Analyst Report?
Serina Therapeutics (SER) Financial Statements
261 Followers
Serina Therapeutics Financial Overview
Serina Therapeutics's market cap is currently $35.87M. The company's EPS TTM is $-1.75; its P/E ratio is -0.77; Serina Therapeutics is estimated to report earnings on March 30, 2027, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 56.00K | $ 3.15M | $ 500.00K | $ 3.46M |
| Gross Profit | $ 0.00 | $ -138.00K | $ 3.06M | $ 500.00K | $ -333.84K |
| Operating Income | $ -24.02M | $ -17.05M | $ -3.13M | $ -2.27M | $ -1.63M |
| EBITDA | $ -18.91M | $ -10.49M | $ 5.92M | $ -2.60M | $ -1.23M |
| Net Income | $ -19.18M | $ -11.14M | $ 5.27M | $ -2.68M | $ -1.26M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.06M | $ 3.67M | $ 7.62M | $ 645.00K | $ 584.00K |
| Total Assets | $ 6.95M | $ 6.72M | $ 8.97M | $ 3.24M | $ 3.15M |
| Total Debt | $ 196.00K | $ 268.00K | $ 3.44M | $ 18.12M | $ 13.20M |
| Net Debt | $ -2.86M | $ -3.40M | $ -4.17M | $ 17.48M | $ 12.62M |
| Total Liabilities | $ 6.99M | $ 6.22M | $ 41.26M | $ 20.56M | $ 15.03M |
| Stockholders' Equity | $ -37.00K | $ 641.00K | $ -32.29M | $ -17.21M | $ -11.83M |
| Cash Flow | |||||
| Free Cash Flow | $ -18.01M | $ -17.16M | $ -2.98M | $ -2.09M | $ -2.36M |
| Operating Cash Flow | $ -17.95M | $ -17.14M | $ -2.48M | $ -2.08M | $ -2.25M |
| Investing Cash Flow | $ -59.00K | $ -22.00K | $ -504.00K | $ 980.94K | $ 823.32K |
| Financing Cash Flow | $ 17.41M | $ 13.21M | $ 10.07M | $ 1.31M | $ 1.08M |
Currency in USD

